4/19/2012 - The Institute of Medicine of the National Academies (IOM), in conjunction with Vanderbilt University School of Medicine, will hold a regional meeting Monday, April 23, 4–6 p.m. in 208 Light Hall.
The presentation, “Potential and Pitfalls of Gene and Omics-Based Treatment for Cancer,” will highlight recent advances in cancer research based on gene sequencing, along with the challenges of dealing with the vast amounts of data generated by these new techniques.
Harvey Fineberg, M.D., Ph.D., president of the IOM, and Jeff Balser, M.D., Ph.D., vice chancellor for Health Affairs and dean of the School of Medicine, will open the session, which features presentations by two Vanderbilt-Ingram Cancer Center research leaders.
Harold (Hal) Moses, M.D., director emeritus of VICC and Hortense B. Ingram Professor of Molecular Oncology, will present “Evolution of Translational Omics: Lessons Learned and the Path Forward.”
William Pao, M.D., Ph.D., director of the Division of Hematology and Oncology and director of Personalized Cancer Medicine at VICC, will discuss “Implementing Genetically Informed Cancer Medicine at Vanderbilt.”
A reception will be held following the presentations.
To register for the event, visit www.iom.edu/TNRegPublic or send an email to iomregTN@nas.edu.©2013 Vanderbilt University Medical Center